Αποτελέσματα Αναζήτησης
29 Ιουλ 2019 · HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
23 Νοε 2015 · Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) today announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global innovative biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader in a new ...
The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. [2]
6 ημέρες πριν · Pfizer and Allergan have confirmed that they will merge in a $160 billion deal, with Ireland-domiciled Allergan acquiring the US pharma giant, and re-naming itself Pfizer.
14 Δεκ 2023 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines.
15 Σεπ 2020 · The European Commission granted final approval to Mylan NV's merger with Pfizer Inc. generics and off-patent drugs unit Upjohn. Viatris — the combination of the Upjohn division, which includes New York-based Pfizer's off-patent drugs like Viagra and Lipitor, and Mylan — had received conditional approval in April, subject to subject to the ...
16 Νοε 2020 · Pfizer Inc. announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.. In the distribution, Pfizer stockholders ...
